Form 8-K - Current report:
SEC Accession No. 0000200406-20-000006
Filing Date
2020-02-13
Accepted
2020-02-12 18:04:25
Documents
14
Period of Report
2020-02-12
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a20200212amendmenttocoi.htm   iXBRL 8-K 49164
  Complete submission text file 0000200406-20-000006.txt   257500

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20200212.xsd EX-101.SCH 5671
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnj-20200212_cal.xml EX-101.CAL 597
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20200212_def.xml EX-101.DEF 16962
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20200212_lab.xml EX-101.LAB 38582
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20200212_pre.xml EX-101.PRE 19058
14 EXTRACTED XBRL INSTANCE DOCUMENT a20200212amendmenttocoi_htm.xml XML 11344
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 20605912
SIC: 2834 Pharmaceutical Preparations